Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Market watch

Forecasting market share in the US pharmaceutical market

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Forecasting the market share of drugs in the US market.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Stephane A. Regnier or David B. Ridley.

Ethics declarations

Competing interests

Stephane A. Régnier is an employee of Novartis Pharma AG. The views in the article are those of the authors, not necessarily those of Novartis Pharma AG.

Related links


Haute Autorité de Santé

PowerPoint slides

Supplementary information

Supplementary information S1 (Box)

Data and analysis methods (PDF 1456 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Regnier, S., Ridley, D. Forecasting market share in the US pharmaceutical market. Nat Rev Drug Discov 14, 594–595 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research